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Abstract Transgenic tobacco (Samsun NN) plants transformed
with a cDNA clone encoding SNA-IP from Sambucus nigra
synthesize, and correctly process and assemble, a fully active
type-2 ribosome-inactivating protein. Expression of SNA-IP
under the control of the 35S cauliflower mosaic virus promoter
enhances the plant’s resistance against infection with tobacco
mosaic virus. In contrast to type-1 ribosome-inactivating
proteins, the expression of SNA-IP does not affect the growth
and fertility of the transgenic plants and is not accompanied by
an increased expression of pathogenesis-related proteins in-
dicating that its antiviral activity most probably differs from
that of pokeweed antiviral protein. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
RNA N-glycosylases (EC 3.2.2.22), also called ‘ribosome-
inactivating proteins’ (RIPs), are an extended and heteroge-
neous family of plant proteins [1^3]. Most RIPs consist of an
N-glycosylase domain of approximately 30 kDa. These RIPs
are usually referred to as type-1 RIPs [3]. Other RIPs are
chimeric proteins consisting of an N-terminal N-glycosylase
domain tandemly arrayed to an unrelated C-terminal domain
corresponding to either a lectin (as in type-2 RIPs) [3] or a
protein with yet unidenti¢ed activity/function (as in the type-3
RIP JIP60) [4].
Though the function of RIPs is still not fully understood it
has been suggested that they are involved in plant defense [3].
Since many type-1 RIPs are potent antiviral proteins in vitro
and experiments with transgenic plants demonstrated that the
type-1 RIPs from Phytolacca americana [5^8], Phytolacca in-
sularis [9], Trichosanthes kirilowii [10] and Dianthus caryophyl-
lus [11] act as antiviral proteins in planta there is an increasing
belief that type-1 RIPs protect the plant against viruses. In
contrast to type-1 RIPs, type-2 RIPs are not commonly con-
sidered antiviral proteins because their protective e¡ect
against plant viruses is poorly documented. Though clear in-
dications for in vitro antiviral activity have been reported for
abrin, ricin and moddecin [12] and for a type-2 RIP from
Eranthis hyemalis [13], no evidence has been presented that
any type-2 RIP exhibits in planta antiviral activity.
To corroborate the in planta antiviral activity of type-2
RIPs a type-2 RIP from Sambucus nigra (elderberry) (called
S. nigra agglutinin IP or SNA-IP) [14] was expressed in Nic-
otiana tabacum Samsun NN. Expression of SNA-IP did not
a¡ect the phenotype and fertility of the transgenic lines but
clearly enhanced their resistance against infection with tobac-
co mosaic virus (TMV) without an apparent increase of the
expression of pathogenesis-related (PR) proteins. Our results
not only demonstrate that a type-2 RIP exhibits in planta
antiviral activity but also indicate that its mode of action
may di¡er from that of the type-1 RIP pokeweed antiviral
protein (PAP).
2. Materials and methods
2.1. Plasmid construction
Standard cloning techniques [15] were used to construct the plasmid
for expression of SNA-IP. The complete coding sequence of SNA-IP
was ampli¢ed by PCR using the cDNA clone LECSNA-IP [14] as a
template with the primers 5P-ATGAAAGTGGTAGCAACAATAT-
TA-3P (5P primer containing SacI site for cloning) and 5P-CTATGC-
TGGATGGGTGCTAGCTAT-3P (3P primer with added NsiI site).
The restriction cassette (1.8 kb) was subcloned into the SacI and
NsiI sites of the plasmid pCR2.1-TOPO (TOPO TA Cloning Kit,
Invitrogen, CA, USA). After con¢rmation of the sequence by the
dideoxy method [16], the plasmid was digested with SacI and NsiI
and the insert cloned into the plant transformation vector pGB19
which was constructed by transfer of the EcoRI^HindIII fragment
of the plasmid pFF19 [17] into pGPTV-BAR [18]. The resulting plas-
mid pGB19-SNA-IP contained the SNA-IP transgene under the control
of the 35S promoter from cauli£ower mosaic virus and the selectable
marker phosphinothricin acetyltransferase (bar) under the control of
the nopaline synthase promoter.
2.2. Transformation of tobacco
Agrobacterium tumefaciens GV3101 was transformed with the plas-
mid pGB19-SNA-IP by electroporation and used for transformation
of tobacco (Samsun NN) leaf discs [19]. Shoots were selected on
Murashige and Skoog medium [20] with 0.1 mg/l K-naphthalene acetic
acid, 1 mg/l 6-benzylaminopurine, 100 mg/l timentin, 100 mg/l cefo-
taxime, 100 mg/l carbenicillin and 5 mg/l phosphinothricin. Resistant
shoots were transferred to Murashige and Skoog medium with 0.1
mg/l K-naphthalene acetic acid, 100 mg/l timentin, 100 mg/l cefotax-
ime, 100 mg/l carbenicillin and 5 mg/l phosphinothricin for rooting.
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2.3. RNA isolation and Northern blot analysis
RNA was prepared from tobacco leaves as described by Eggermont
et al. [21], dissolved in RNase-free water and quantitated spectropho-
tometrically. Approximately 30 Wg of total RNA was denatured in
glyoxal and dimethylsulfoxide according to Sambrook et al. [15], and
separated in a 1.2% (w/v) agarose gel. Following electrophoresis the
RNA was transferred to Immobilon N membranes (Millipore, Bed-
ford, MA, USA) and the blot hybridized [22] using a random-primer-
labelled cDNA insert or a speci¢c oligonucleotide probe for SNA-IP.
Alternatively the blot was hybridized with probes encoding tobacco
PR-1 and PR-3 proteins, and a wound-inducible protein kinase.
2.4. Isolation of SNA-IP and recombinant SNA-IP
SNA-IP was isolated from elderberry bark as described previously
[14]. Recombinant SNA-IP (rSNA-IP) was puri¢ed from tobacco leaves
using the same procedure based on a⁄nity chromatography on im-
mobilized fetuin. The a⁄nity-puri¢ed lectin was dialyzed against ap-
propriate bu¡ers and stored at 320‡C until use.
2.5. Analytical methods
Crude extracts and puri¢ed proteins were analyzed by SDS^PAGE
using 15% (w/v) acrylamide gradient gels as described by Laemmli
[23]. Analytical gel ¢ltration was performed on a Pharmacia Superose
12 column (Amersham Pharmacia Biotech, Uppsala, Sweden) using
0.1 M Tris^HCl (pH 8.7) containing 0.2 M NaCl and 0.2 M galactose
as running bu¡er. The elderberry bark type-2 RIPs SNA-I (240 kDa)
[24], SNA-V (120 kDa) [25] and SNLRP (60 kDa) [26] were used as
molecular mass markers.
Protein concentration was determined with the Bradford assay [27]
using SNA-I as a standard.
2.6. Agglutination and RNA N-glycosylase activity assays
Agglutination assays were done in 96 U-welled microtiter plates in a
¢nal volume of 50 Wl containing 40 Wl of a 1% suspension of trypsi-
nized rabbit erythrocytes and 10 Wl of extracts or lectin solutions.
Agglutination was assessed visually after 1 h at room temperature.
The RNA N-glycosylase activity of SNA-IP and rSNA-IP was esti-
mated using the method of Endo and Tsurugi [28] with some minor
modi¢cations. Ribosomes were incubated with puri¢ed RIPs in 25
mM Tris^HCl (pH 7.4) containing 25 mM KCl and 5 mM MgCl2
at the appropriate temperature (37‡C and 25‡C for rabbit reticulocyte
lysate and wheat germ ribosomes, respectively). After incubation total
ribosomal RNA was extracted, dissolved in distilled H2O and divided
into two parts. One part was used as a control and the other was
treated with a freshly prepared 1.0 M solution of acidic aniline (pH
4.5) at room temperature in the dark for 10 min to cleave the so-called
Endo fragment. The RNA was analyzed in a 1.2% agarose^formam-
ide gel. Gels were stained with 0.5 mg/ml ethidium bromide and pho-
tographed on a UV transilluminator.
2.7. Protein extraction and Western blot analysis
Samples (200 mg) of tobacco leaves were homogenized in 1 ml of 50
mM acetic acid using a Fastprep system and centrifuged at 13 000Ug
for 5 min. Aliquots (200 Wl) of the cleared extracts were lyophilized
and dissolved in 20 Wl of loading bu¡er (0.1 M Tris^HCl pH 7.8, 4%
SDS, 10% glycerol containing 0.1% bromophenol blue and 1% L-mer-
captoethanol). After electrophoresis, proteins were transferred to an
Immobilon P membrane (Millipore, Bedford, MA, USA) using a
semi-dry blotting system. Immunodetection was carried out as de-
scribed by Desmyter et al. [29] using an a⁄nity-puri¢ed polyclonal
rabbit antibody raised against SNA-I from elderberry bark as the
primary antibody.
2.8. Bioassay with TMV
Seeds of transgenic tobacco were sterilized by successive soaking in
70% ethanol and a solution of 5% NaOCl containing 0.05% Tween 20
before selection on MS medium containing 5 mg/l phosphinothricin.
Seedlings with a healthy phenotype in the two-leaf stage were trans-
ferred to soil. In a later stage, the plants were checked for the ex-
pression of the lectin by a simple agglutination test on a small leaf
sample. Only plants giving a strong agglutination activity were used
for the experiments. When the selected plants reached the six-leaf
stage the upper two fully expanded leaves were mechanically infected
with TMV (strain TMV vulgare) by rubbing the virus suspension in
100 mM phosphate bu¡er (pH 7.2) containing 2% polyvinylpyrroli-
done in the presence of carborundum powder on the leaves. Inocu-
lated plants were kept in a greenhouse (16 h light, 55% humidity, 20^
21‡C day and 18^19‡C night temperature) and after 4 days the num-
ber of local lesions on the infected leaves was counted. The size of the
lesions (10 per plant) was measured under a microscope 7 days post-
infection. Data obtained from each experiment were analyzed sepa-
rately for statistical signi¢cance using SAS software [30].
3. Results
3.1. Selection and characterization of transgenic tobacco plants
Twelve independent phosphinothricin-resistant tobacco
lines were regenerated from leaf discs transformed with A.
tumefaciens harboring the vector pGB19-SNA-IP. Seven lines
(designated 26101^26107) yielded a fragment with an expected
size of 1.8 kb after PCR ampli¢cation of genomic DNA using
speci¢c primers for the complete coding sequence of LECS-
NA-IP (data not shown). Northern blot analysis using a probe
speci¢c for SNA-IP yielded clear hybridization signals for ¢ve
out of seven putative transformants (Fig. 1A) whereas RNA
from untransformed tobacco yielded no signal after hybridi-
zation with the same probe. Western blot analysis of crude
leaf extracts con¢rmed that these ¢ve lines express polypep-
tides of approximately 35 kDa that react with antibodies
against SNA-I (Fig. 1B) and are absent from untransformed
tobacco plants. Calculations based on comparative agglutina-
tion assays (using puri¢ed SNA-IP as a standard) indicated
that the expression level of SNA-IP in the transgenic plants
varied between 0.25 and 2.5 Wg/m protein. All tobacco plants
expressing SNA-IP showed a normal phenotype.
3.2. Puri¢cation and characterization of recombinant SNA-IP
rSNA-IP was puri¢ed from leaves of transgenic tobacco
plants. The overall yield was approximately 7.5 mg/kg leaves
(fresh weight). SDS^PAGE under non-reducing conditions
yielded a single polypeptide chain of approximately 65 kDa
for both rSNA-IP and SNA-IP. Under reducing conditions
both type-2 RIPs yielded two polypeptides of approximately
35 kDa (results not shown). Native SNA-IP and rSNA-IP
eluted at exactly the same position upon gel ¢ltration on a
Superose 12 column (results not shown) indicating that both
Fig. 1. A: Northern blot analysis of transformed tobacco lines. The
blot was hybridized using a random-primer-labelled oligonucleotide
probe speci¢c for SNA-IP. B: Western blot analysis of transformed
tobacco lines. Speci¢c antibodies were used for the detection of
SNA-IP after blotting of the proteins. Samples were loaded as fol-
lows: lane P, pure SNA-IP from elderberry; lane N, untransformed
tobacco plant; lanes 1^7, transformed tobacco lines 26101, 26102,
26103, 26104, 26105, 26106 and 26017, respectively. According to
densitometric analyses the expression level of SNA-IP in transgenic
lines 26103, 26104, 26105, 26106 and 26017 corresponds to 2.52,
1.64, 0.66, 1.41 and 1.11 Wg/mg total soluble protein, respectively.
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the native and the recombinant protein are dimeric type-2 RIP
with the same [A-s-s-B]2 structure. According to these data
the cells of transgenic tobacco plants synthesize and correctly
process and assemble SNA-IP.
RNA N-glycosylase assays demonstrated that rSNA-IP acts
as an RNA N-glycosylase on rabbit reticulocyte but not on
wheat germ ribosomes (Fig. 2). Parallel experiments with
SNA-IP yielded identical results. rSNA-IP and SNA-IP were
equally active the minimal concentration required for RNA
N-glycosylase activity being 50 pM.
Semi-quantitative agglutination assays indicated that
rSNA-IP and SNA-IP are equally active, the minimal concen-
tration required for the agglutination of trypsin-treated rabbit
erythrocytes being 40 Wg/ml. Moreover, rSNA-IP and SNA-IP
are also equally sensitive towards lactose (20 mM) and fetuin
(125 Wg/ml), suggesting that the B-chain of the recombinant
lectin exhibits the same carbohydrate-binding speci¢city as
SNA-IP.
3.3. Expression of SNA-IP enhances the resistance of tobacco
plants against infection with TMV without increasing the
expression of PR proteins
Transgenic tobacco plants expressing the SNA-IP were me-
chanically infected with TMV and the development of symp-
toms of viral infection compared to those occurring in un-
transformed control plants. Both the number of lesions and
the lesion size was reduced in the transgenic lines (Table 1 and
Fig. 3), which clearly indicates that the expression of SNA-IP
enhances the resistance of transgenic tobacco plants against
infection with TMV.
A comparison of the levels of transcripts encoding PR-1
and PR-3 proteins, and wound-inducible protein kinase by
Northern blot analysis did not show any detectable di¡erence
between the transgenic lines and untransformed plants neither
in young nor in old leaves (results not shown).
4. Discussion
During the last decade conclusive evidence was reported
that the expression of the type-1 RIPs from P. americana
[5^8] and T. kirilowii [10] protects transgenic tobacco and
potato plants against infection with various plant viruses.
To corroborate whether type-2 RIPs also increase the plant’s
resistance against viruses, the gene encoding SNA-IP from
elderberry was transferred into tobacco and the resulting
transgenic plants tested for resistance against TMV infection.
Transgenic tobacco plants expressing SNA-IP clearly exhibit
an increased resistance against infection with TMV. These
results demonstrate for the ¢rst time that a type-2 RIP exerts
antiviral activity in planta, which strongly suggests that not
only type-1 RIPs but also type-2 RIPs may be involved in
plant defense. In contrast to many type-1 RIPs, the ectopic
expression of SNA-IP causes no visible phenotype indicating
that this elderberry type-2 RIP exerts no cytotoxic e¡ects in
planta. This obvious absence of a phenotype strikingly con-
trasts with the detrimental e¡ects of ectopically expressed
type-1 and type-3 RIP. For example, tobacco plants express-
ing PAP at a concentration of s 10 ng/mg protein showed a
stunted, mottled phenotype and plants with the highest ex-
pression level were sterile [5]. Expression of the type-3 RIP
JIP60 in transgenic tobacco under the control of a constitutive
Fig. 2. RNA N-glycosylase activity of native and recombinant
SNA-IP towards rabbit reticulocyte lysate ribosomes. RNA bands
were visualized by ethidium bromide staining. (3) and (+) indicate
no treatment and aniline treatment, respectively. The arrow indi-
cates the position of the Endo fragment released from the rRNA.
Samples were loaded as follows: lanes 1^2, 1 mM native SNA-IP ;
lanes 3^4, 1 mM rSNA-IP ; lanes 5^6, crude protein extract of un-
transformed tobacco.
Table 1
E¡ect of the ectopic expression of SNA-IP on the infection of trans-
genic tobacco plants with TMV
Plant line Number of lesions per leafa Lesion sizeb
total number % of control mm % of control
Wild type 102 100 2.15 100
26103 42 41** 1.22 57**
26104 49 48** 1.48 69*
26106 84 82* 1.63 75*
26107 84 82* 1.66 77*
*P6 0.05, **P6 0.01, signi¢cantly di¡erent from wild type.
aThe number of local lesions on the infected leaves was counted
after 4 days. Individual values for lesion numbers are the means of
three replicates.
bThe size of the lesions (six per plant) was measured under a micro-
scope 7 days post-infection.
Fig. 3. Development of local lesions on the leaves of untransformed
tobacco plant and transgenic line 26103 upon infection with TMV.
The picture was taken 4 days post-infection.
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promoter also resulted in reduced growth, shorter internodes,
lanceolate leaves, reduced root development and premature
leaf senescence [31]. The obvious absence of a phenotype in
the tobacco plants expressing SNA-IP cannot be ascribed to a
low expression level of the type-2 RIP. On the contrary, the
expression level of SNA-IP in our experiments (up to 2.5 Wg/
mg protein) exceeds the expression levels of PAP (10 ng/mg
protein) [5] and PAP II (150 ng/mg protein) [8] that caused a
phenotype in tobacco by a factor 250 and 17, respectively.
In contrast to wild-type PAP and various PAP mutants the
ectopic expression of SNA-IP is not accompanied by enhanced
expression of wound-induced protein kinase and PR-1 and
PR-3 proteins in transgenic tobacco [6,7,32]. This observation
is important because it indicates that the proposed mode of
action of type-1 RIPs, which according to the latest ideas
relies on a salicylic acid-independent signal transduction path-
way reminiscent of the wounding response [3,7,32], cannot
simply be extrapolated to SNA-IP. It is questionable, there-
fore, whether the observed in planta antiviral activity of the
elderberry type-2 RIP results from the same activation of an
innate plant defense system as that proposed for PAP. This
may also explain why the in planta protective e¡ect of SNA-IP
is apparently lower than that of PAP and other type-1 RIPs.
Analysis of SNA-IP isolated from transgenic tobacco dem-
onstrated that the recombinant protein exhibits virtually the
same enzymatic and carbohydrate-binding activities as native
SNA-IP from elderberry bark, indicating that the tobacco cells
synthesize and correctly process and assemble this elderberry
type-2 RIP. Hitherto, only the monomeric type-2 RIP ricin
was expressed in tobacco plants [33]. Our results demonstrate
for the ¢rst time that transgenic tobacco is capable of express-
ing not only a simple monomeric type-2 RIP like ricin but
also an oligomeric type-2 RIP with a complex structure.
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